Gurion Reut, Tangpricha Vin, Yow Eric, Schanberg Laura E, McComsey Grace A, Robinson Angela Byun
Division of Pediatric Infectious Diseases, Rheumatology and Global Health, Department of Pediatrics, Rainbow Babies and Children's Hospital/Case Medical Center, Cleveland, OH, USA.
Division of Endocrinology, Metabolism & Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Pediatr Rheumatol Online J. 2015 Apr 23;13:13. doi: 10.1186/s12969-015-0008-x.
Avascular necrosis (AVN) occurs in several chronic illnesses, including systemic lupus erythematosus (SLE), but can also occur in healthy children. There are multiple theories to explain why and how AVN occurs, but an exact mechanism has yet to be unraveled. AVN in the pediatric lupus population is understudied. The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) trial, provides an excellent venue to conduct an exploratory analysis to assess associations between AVN and demographics, SLE disease activity and vitamin D deficiency. Herein we present a brief report describing our findings, as well as reviewing the literature on AVN in SLE and other entities.
ClinicalTrials.gov identifier: NCT00065806.
无血管性坏死(AVN)发生于多种慢性疾病,包括系统性红斑狼疮(SLE),但也可发生于健康儿童。有多种理论解释AVN发生的原因及机制,但确切机制尚未阐明。儿科狼疮患者中的AVN研究不足。儿科狼疮性动脉粥样硬化预防(APPLE)试验为进行探索性分析提供了一个绝佳场所,以评估AVN与人口统计学、SLE疾病活动及维生素D缺乏之间的关联。在此,我们给出一份简短报告描述我们的发现,并回顾关于SLE及其他疾病中AVN的文献。
ClinicalTrials.gov标识符:NCT00065806。